Use App
  • NewConnect your Agent
  • Trending
  • News
  • Earnings
DIADIA0.53%
SPYSPY0.39%
QQQQQQ0.18%
Trending
Top trending tickerCOMPCOMP3.63%
ZECZEC15.72%
SQQQSQQQ0.42%
AAOIAAOI5.13%
TQQQTQQQ0.47%
RETIRERETIRE9.24%
XRPXRP0.94%
UNIUNI11.46%
CSIQCSIQ2.29%
SOXSSOXS10.19%

Feed

News

Sentiment

Fundamentals

Info

homeSymbolCELG

CELG Celgene Corporation

53

Neutral Sentiment

How do you feel about CELG?

Advertisement|Remove ads.

Latest CELG News

View
Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European Society of Cardiology (ESC) Congress 2026
Business Wire
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
Nasdaq News: Markets
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse
Business Wire
Loading...
Top Discussions
StocktwitsPollsStocktwitsPolls
How many rate hikes do you expect from the Fed in 2026?
118
209
29.9K votes
StocktwitsPollsStocktwitsPolls
What's the biggest risk to the market right now?
204
113
16.5K votes
TTWOTTWO
Take-Two ($TTWO) shares are down 7% today. Are you buying the dip?
3
1
746 votes

Advertisement|Remove ads.

Advertisement|Remove ads.

Home
TrendingNews
Profile